share_log

HC Wainwright & Co. Reiterates Buy on Candel Therapeutics, Maintains $11 Price Target

HC Wainwright & Co. Reiterates Buy on Candel Therapeutics, Maintains $11 Price Target

HC Wainwright & Co.重申買入Candel Therapeutics,維持11美元的目標股價
Benzinga ·  2023/05/22 06:16

HC Wainwright & Co. analyst Vernon Bernardino reiterates Candel Therapeutics (NASDAQ:CADL) with a Buy and maintains $11 price target.

HC Wainwright & Co. 分析師弗農·貝納迪諾重申Candel Therapeutics(納斯達克股票代碼:CADL)的買入並維持11美元的目標股價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論